Extending our reach so you can extend yours

Affymetrix is adding new genetic analysis technologies to streamline workflows and help you revolutionize life

After pioneering the microarray technology used to publish more than 20,000 scientific papers, Affymetrix is evolving into a provider of scalable, innovative genomic analysis tools and reagents for discovery, exploration, validation, and genetic testing. The acquisitions of Panomics and USB bring high-throughput, multi- to single-gene assays and premium molecular biology reagents to our customers, enabling a complete solution for genome-wide to cellular and protein analysis studies.

More >

What's New

GeneAtlas System™

More >

Axiom™ Genotyping Solution

More >

USB® Poly(A) Tail-Length Assay Kit

More >

Anatrace® Bicelle Kit

More >

News

3/15/2010

Timothy Barabe Appointed Chief Financial Officer of Affymetrix

3/3/2010

Affymetrix Appoints Jami Dover Nachtsheim and Nelson C. Chan to Board of Directors

View All >

Events

Affymetrix at Barclays Capital Global Healthcare Conference

3/23/10-3/23/10

Affymetrix at Cowen and Company Healthcare Conference

3/9/10-3/9/10

View All >